Compare Pfizer Inc (PFE) vs Invesco NASDAQ 100 ETF (QQQM) Price & Performance

Pfizer IncTrade

Invesco NASDAQ 100 ETFTrade

Price performance (Past 24H)

Key statistics

Pfizer Inc vs Invesco NASDAQ 100 ETF — how do they compare? Pfizer Inc trades at $27.9 (market cap $158.39B), while Invesco NASDAQ 100 ETF trades at $295.07. The key difference: Pfizer Inc pays a 6.19% dividend while Invesco NASDAQ 100 ETF pays none. Which is the better fit depends on your goals.

	PFE	QQQM
Market Cap	$158.39B	—
Volume	29,869,932	—
Sector	Health	Broad Market / Factor
52-Week High	$29.02	$307.23
52-Week Low	$23.60	$229.87
Enterprise Value	$209.89B	—
Dividend Yield	6.19%	—

View details →View details →

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Pfizer Inc

Pfizer (PFE) trades at $27.78, down 2.36% today, with a consensus price target of $28.33 suggesting modest upside. The stock shows mixed technical signals with bullish moving averages but neutral oscillators. Recent earnings have consistently beaten expectations, though revenue declined from pandemic peaks. The company maintains strong cash flow generation and a solid dividend yield of approximately 3.1%.

Pfizer presents a value opportunity with reasonable valuation metrics and dividend stability, but faces headwinds from post-COVID revenue normalization and patent expirations. The company's pipeline progress in obesity and oncology could drive future growth, though execution risks remain. Analyst sentiment leans cautious with 59% hold ratings.

Invesco NASDAQ 100 ETF

QQQM trades at $295.76, down 0.1% with a bullish technical signal from moving averages. The ETF tracks the Nasdaq-100 index, offering diversified exposure to large-cap growth stocks. Recent news highlights QQQM's low expense ratio advantage over QQQ and its position as a core growth allocation option for investors seeking Nasdaq-100 exposure.

The outlook remains positive for long-term growth investors, with technical indicators supporting bullish momentum. Key risks include concentration in top holdings and market sensitivity to technology sector performance. The ETF's low-cost structure provides a competitive advantage for sustained investment.

Aura AI is an analytical signal, not financial advice — do your own research.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

PFE

Dividend Harvesting Portfolio hits 45.8% ROI with 7.83% yield, adding Pfizer and AGNC for income growth.Seeking Alpha · 1 day agoBullish Pfizer stock offers 13.8% upside plus a 5.91% dividend amid strong pipeline and cost savings.24/7 Wall Street · 2 days agoBullish View details →

QQQM

TQQQ returned 59.18% vs. QQQ's 24.99%, but leverage costs and daily resets reduce its triple return over time.24/7 Wall Street · 13 hours agoNeutral SCHG preferred over QQQM for broader growth exposure and lower cost, while QQQM suits pure Nasdaq-100 focus.Seeking Alpha · 20 hours agoBullish QQQM ETF offers lower fees than QQQ, saving investors thousands over decades with identical Nasdaq-100 exposure.24/7 Wall Street · 1 day agoNeutral View details →

About Pfizer Inc

Pfizer Inc. operates as a pharmaceutical company. The Company offers medicines, vaccines, medical devices, and consumer healthcare products for oncology, inflammation, cardiovascular, and other therapeutic areas. Pfizer serves customers worldwide.

About Invesco NASDAQ 100 ETF

QQQM is an ETF designed to track the performance of the NASDAQ-100 Index. It provides exposure to the 100 largest non-financial companies listed on the NASDAQ. Positioned as a lower-cost and more long-term-investor-friendly alternative to its peer QQQ, QQQM offers the same fundamental market exposure but typically has a lower share price and is structured to appeal to investors focused on accumulation rather than active trading.